Clinical trial
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant…
NCT00490659 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00490659 |
|---|---|
| Title | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes |
| Official title | A Phase II Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (-With Weekly Low-Dose Gemcitabine) in the Treatment of Nodes Positive NSCLC Patients |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | gemcitabine, cisplatin, radical surgery, chemoradiotherapy |
| Enrollment | 13 |
| Start date | Sep 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Jun 25, 2007 |
| Last update posted | Jun 25, 2007 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: